Literature DB >> 20971617

Increased hypoglycemia associated with renal failure during continuous intravenous insulin infusion and specialized nutritional support.

Roland N Dickerson1, Leslie A Hamilton, Kathryn A Connor, George O Maish, Martin A Croce, Gayle Minard, Rex O Brown.   

Abstract

OBJECTIVE: To evaluate glycemic control for critically ill, hyperglycemic trauma patients with renal failure who received concurrent intensive insulin therapy and continuous enteral nutrition (EN) or parenteral nutrition (PN).
METHODS: Adult trauma patients with renal failure who were given EN or PN concurrently with continuous graduated intravenous regular human insulin (RHI) infusion for at least 3 d were evaluated. Our conventional RHI algorithm was modified for those with renal failure by allowing greater changes in blood glucose (BG) concentrations before the infusion rate was escalated. BG concentration was determined every 1 to 2 h while receiving the insulin infusion. BG control was evaluated on the day before RHI infusion and for a maximum of 7 d while receiving RHI. Target BG during the RHI infusion was 70 to 149 mg/dL (3.9 to 8.3 mmol/L). Glycemic control and incidence of hypoglycemia for those with renal failure were compared with a historical cohort of critically ill, hyperglycemic trauma patients without renal failure given our conventional RHI algorithm.
RESULTS: Twenty-one patients with renal failure who received the modified RHI algorithm were evaluated and compared with 40 patients without renal failure given our conventional RHI algorithm. Average BG concentration was significantly greater for those with renal failure (133±14 mg/dL or 7.3±0.7 mmol/L) compared with those without renal failure (122±15 mg/dL or 6.8±0.8 mmol/L), respectively (P<0.01). Patients with renal failure showed worsened glycemic variability, with 16.1±3.3 h/d within the target BG range, 6.9±3.2 h/d above the target BG range, and 1.4±1.1 h/d below the target BG range compared with 19.6±4.7 h/d (P<0.001), 3.4±3.0 h/d (P<0.001), and 0.7±0.8 h/d (P<0.01) for those without renal failure, respectively. Moderate hypoglycemia (<60 mg/dL or<3.3 mmol/L) occurred in 76% of patients with renal failure compared with 35% without renal failure (P<0.005). Severe hypoglycemia (BG<40 mg/dL or<2.2 mmol/L) occurred in 29% of patients with renal failure compared with none of those without renal failure (P<0.001).
CONCLUSION: Despite receiving a modified RHI infusion, critically ill trauma patients with renal failure are at greater risk for developing hypoglycemia and have more glycemic variability than patients without renal failure.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20971617     DOI: 10.1016/j.nut.2010.08.009

Source DB:  PubMed          Journal:  Nutrition        ISSN: 0899-9007            Impact factor:   4.008


  8 in total

1.  Provision of balanced nutrition protects against hypoglycemia in the critically ill surgical patient.

Authors:  Rondi M Kauffmann; Rachel M Hayes; Judith M Jenkins; Patrick R Norris; Jose J Diaz; Addison K May; Bryan R Collier
Journal:  JPEN J Parenter Enteral Nutr       Date:  2011-07-12       Impact factor: 4.016

2.  Hypocaloric enteral nutrition protects against hypoglycemia associated with intensive insulin therapy better than intravenous dextrose.

Authors:  Rondi M Kauffmann; Rachel M Hayes; Amanda H VanLaeken; Patrick R Norris; Jose J Diaz; Addison K May; Bryan R Collier
Journal:  Am Surg       Date:  2014-11       Impact factor: 0.688

3.  Increasing blood glucose variability heralds hypoglycemia in the critically ill.

Authors:  Rondi M Kauffmann; Rachel M Hayes; Brad D Buske; Patrick R Norris; Thomas R Campion; Marcus Dortch; Judith M Jenkins; Bryan R Collier; Addison K May
Journal:  J Surg Res       Date:  2011-03-31       Impact factor: 2.192

4.  Incidence of Hypoglycemia in Burn Patients: A Focus for Process Improvement.

Authors:  David M Hill; Sean Lloyd; William L Hickerson
Journal:  Hosp Pharm       Date:  2017-12-07

5.  End-Stage Renal Disease Increases Rates of Adverse Glucose Events When Treating Diabetic Ketoacidosis or Hyperosmolar Hyperglycemic State.

Authors:  Caitlin M Schaapveld-Davis; Ana L Negrete; Joanna Q Hudson; Jagannath Saikumar; Christopher K Finch; Mehmet Kocak; Pan Hu; Megan A Van Berkel
Journal:  Clin Diabetes       Date:  2017-10

Review 6.  Prevention of acute kidney injury and protection of renal function in the intensive care unit: update 2017 : Expert opinion of the Working Group on Prevention, AKI section, European Society of Intensive Care Medicine.

Authors:  M Joannidis; W Druml; L G Forni; A B J Groeneveld; P M Honore; E Hoste; M Ostermann; H M Oudemans-van Straaten; M Schetz
Journal:  Intensive Care Med       Date:  2017-06-02       Impact factor: 17.440

7.  Exploring pancreatic pathology in Plasmodium falciparum malaria patients.

Authors:  Supattra Glaharn; Chuchard Punsawad; Stephen A Ward; Parnpen Viriyavejakul
Journal:  Sci Rep       Date:  2018-07-11       Impact factor: 4.379

Review 8.  Diabetic Ketoacidosis in Patients with End-stage Kidney Disease: A Review.

Authors:  Abdulmajeed Al Sadhan; Elwaleed ElHassan; Abdulrahman Altheaby; Yousef Al Saleh; Mahfooz Farooqui
Journal:  Oman Med J       Date:  2021-03-31
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.